GlassScriptPhysician profile
Sydney Saxena
NPI 1972532810
$21,408.06
in general payments reported to CMS, 2019-2025
43 companies · $3,579 in 2025
The $3,579 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2021: $724 · 2022: $1,573 · 2023: $2,007 · 2024: $13K · 2025: $3,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $4,221 · Travel and Lodging: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,480.00 |
| Food and Beverage | $4,221.43 |
| Travel and Lodging | $1,041.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16,323.16 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $1,005.87 | 2021-2025 | Qulipta, Linzess, Ubrelvy |
| Pfizer INC. | $458.93 | 2019-2024 | |
| Lilly USA, LLC | $344.11 | 2022-2023 | Mounjaro, Jardiance |
| Teva Pharmaceuticals USA, INC. | $277.63 | 2021-2023 | Austedo Xr |
| Glaxosmithkline, LLC. | $257.33 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $233.18 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $225.55 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $132.83 | 2023 | Rexulti |
| Portola Pharmaceuticals, LLC | $126.53 | 2019 | |
| Angiodynamics, INC. | $125.00 | 2023 | Auryon Laser System 100-120 Vac |
| Aimmune Therapeutics, INC. | $124.50 | 2024 | |
| Tesaro, INC. | $121.73 | 2019 | |
| Axsome Therapeutics, INC. | $120.95 | 2023 | Auvelity |
| Shionogi INC | $120.82 | 2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Saxena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.